Metabolism and Target Organ Damage
Overview
Metabolism and Target Organ Damage is a scientific journal, published since 2021 in English. The journal's country of origin is United States.
Details
Details
Abbr.
Metab Target Organ Damage
Start
2021
End
Continuing
Frequency
Quarterly
e-ISSN
2769-6375
Country
United States
Language
English
Metrics
Metrics
h-index / Ranks: 15157
6
SJR / Ranks: 6098
721
Recent Articles
1.
Aldroubi B, Najjar J, Youssef T, Rizk C, Abuamreh B, Aramouni K, et al.
Metab Target Organ Damage
. 2024 Dec;
4(4).
PMID: 39640841
The incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) has reached an epidemic rise worldwide. The disease is a constellation of a broad range of metabolic and histopathologic abnormalities. It...
2.
Rodrigues K, Hussain R, Cooke S, Zhang G, Zhang D, Yin L, et al.
Metab Target Organ Damage
. 2024 Aug;
3(4).
PMID: 39193224
Acetaminophen (APAP) is the most widely used analgesic in the world. APAP overdose can cause severe hepatotoxicity and therefore is the most common cause of drug-induced liver injury. The only...
3.
Kim A, Cajigas-Du Ross C, Dasarathy J, Bellar A, Streem D, Welch N, et al.
Metab Target Organ Damage
. 2024 Aug;
2(4).
PMID: 39148503
Aim: Metabolic liver diseases, including alcohol- and non-alcoholic fatty liver diseases (ALD/NAFLD), are characterized by inflammation and decreased ability to prevent infections. Patients with severe alcohol-associated hepatitis (sAH) are particularly...
4.
Sinacore D, Jones M, Kline P
Metab Target Organ Damage
. 2024 Jun;
4(2).
PMID: 38827187
Aim: The purpose is to determine the risk ratios (RR) for both major adverse foot events (MAFEs) and the presence of moderate and severe functional mobility deficits in participants with...
5.
Wentworth B, Caldwell S
Metab Target Organ Damage
. 2022 Sep;
1(1).
PMID: 36090909
Interpretation of diagnostic and surveillance laboratory results and imaging in liver disease is fraught with misinterpretation and/or uncertainty. Nonalcoholic fatty liver disease (NAFLD) represents an ever-growing proportion of liver disease...
6.
Lonardo A, Singal A, Osna N, Kharbanda K
Metab Target Organ Damage
. 2022 Sep;
2(3).
PMID: 36090199
Primary nonalcoholic fatty liver disease (NAFLD) is bi-directionally associated with the metabolic syndrome and its constitutive features ("factors": impaired glucose disposal, visceral obesity, arterial hypertension, and dyslipidemia). Secondary NAFLD occurs...
7.
Bril F, Godinez Leiva E, Lomonaco R, Shrestha S, Kalavalapalli S, Gray M, et al.
Metab Target Organ Damage
. 2022 Aug;
2.
PMID: 36017449
Aim: The optimal screening strategy for advanced liver fibrosis in overweight and obese patients is unknown. The aim of this study is to compare the performance of different strategies to...